• FY26 revenue increased by 9.9% to $614 million
• Completed $360 million DC renewal program
• Underlying NPAT of $250 million
• Healthcare and Animal Care segments delivered growth
• Executed two key acquisitions for $26 million

EBOS Group Ltd has announced its FY26 results, showing a 9.9% increase in revenue to $614 million. The company completed a four-year, $360 million distribution center (DC) renewal program, with all facilities now operational. The underlying net profit after tax (NPAT) was $250 million. The Healthcare segment saw revenue increase by 8.5%, driven by growth in Community Pharmacy, Hospital Medicines, Medical Technology, and Contract Logistics. The Animal Care segment reported a 34.6% revenue increase, driven by the acquisition of SVS and growth in the Lyppard business. The company also executed two key acquisitions for a total of $26 million, with Paringa providing chilled & fresh pet food capability and K-talyst scaling the aesthetics portfolio across Southeast Asia/Hong Kong. EBOS Group Ltd remains focused on its growth strategy, with a continued shift towards higher-growth, higher return businesses.

FY27 guidance considers a likely range of both FX & fuel impacts

EBOS Group Ltd remains focused on its growth strategy, with a continued shift towards higher-growth, higher return businesses.